Moderately bullish activity in Novo Nordisk (NVO), with shares up $2.08, or 4.61%, near $47.05. Options volume running well above average with 194k contracts traded and calls leading puts for a put/call ratio of 0.65, compared to a typical level near 0.61. Implied volatility (IV30) is higher by 1.7 points near 41.51,and below the 52wk median, suggesting an expected daily move of $1.23. Put-call skew flattened, suggesting a modestly bullish tone, following a downgrade to Hold at HSBC.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
- Novo Nordisk: Amycretin phase 2 trial reports significant weight loss
- Novo Nordisk Reports Positive Phase 2 Results for Amycretin in Type 2 Diabetes
- Novo Nordisk Stock (NVO) Rises on Weight Loss Drug Results
- Novo Nordisk price target lowered to $46 from $50 at BMO Capital